CA2661699A1 - Method of diagnosis - Google Patents

Method of diagnosis Download PDF

Info

Publication number
CA2661699A1
CA2661699A1 CA002661699A CA2661699A CA2661699A1 CA 2661699 A1 CA2661699 A1 CA 2661699A1 CA 002661699 A CA002661699 A CA 002661699A CA 2661699 A CA2661699 A CA 2661699A CA 2661699 A1 CA2661699 A1 CA 2661699A1
Authority
CA
Canada
Prior art keywords
expression
set out
genes
scar
keloid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002661699A
Other languages
English (en)
French (fr)
Inventor
Mark William James Ferguson
Hugh Gerard Laverty
Nicholas Occleston
Sharon O'kane
Darren Hodgson
Neil French
Claire Cridland
Philip Roby
Ardeshir Bayat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Renovo Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2661699A1 publication Critical patent/CA2661699A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA002661699A 2006-08-31 2007-08-28 Method of diagnosis Abandoned CA2661699A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0617116.9A GB0617116D0 (en) 2006-08-31 2006-08-31 Method of diagnosis
GB0617116.9 2006-08-31
PCT/GB2007/003221 WO2008025961A2 (en) 2006-08-31 2007-08-28 Method of diagnosis

Publications (1)

Publication Number Publication Date
CA2661699A1 true CA2661699A1 (en) 2008-03-06

Family

ID=37137073

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002661699A Abandoned CA2661699A1 (en) 2006-08-31 2007-08-28 Method of diagnosis

Country Status (8)

Country Link
US (1) US20090305279A1 (https=)
EP (1) EP2059611A2 (https=)
JP (1) JP2010502177A (https=)
AU (1) AU2007291074A1 (https=)
CA (1) CA2661699A1 (https=)
GB (1) GB0617116D0 (https=)
WO (1) WO2008025961A2 (https=)
ZA (1) ZA200900638B (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013144672A1 (en) * 2012-03-30 2013-10-03 Société De Développement Et De Recherche Industrielle Method and kit for the classification and prognosis of wounds
US8877185B2 (en) 2012-05-10 2014-11-04 Stan S. Sastry Managing and treating keloids
KR101943434B1 (ko) * 2015-06-26 2019-01-30 순천향대학교 산학협력단 켈로이드 조직 진단용 바이오 마커 조성물 및 이를 포함하는 키트
KR101667900B1 (ko) * 2016-01-15 2016-10-21 테고사이언스 (주) 켈로이드성 피부 또는 켈로이드 흉터 진단용 바이오마커 단백질 및 이의 이용
CN109917140A (zh) * 2019-04-09 2019-06-21 潍坊市康华生物技术有限公司 一种柯萨奇病毒A6型和A10型IgM抗体联合检测的试剂条及其制备方法
CN115616215B (zh) * 2021-07-13 2026-03-06 上海交通大学医学院附属第九人民医院 一种瘢痕诊断试剂及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998021331A1 (en) * 1996-11-12 1998-05-22 Incyte Pharmaceuticals, Inc. Human breast tumor-specific proteins
EP1511738A4 (en) * 2002-05-17 2007-05-09 Scios Inc TREATMENT OF FIBROPROLIFERATIVE DISEASES USING TGF BETA INHIBITORS
CN1323165C (zh) * 2003-05-26 2007-06-27 北京大学第三医院 瘢痕疙瘩与增生性瘢痕差异表达基因文库及其构建方法

Also Published As

Publication number Publication date
GB0617116D0 (en) 2006-10-11
US20090305279A1 (en) 2009-12-10
AU2007291074A1 (en) 2008-03-06
WO2008025961A2 (en) 2008-03-06
ZA200900638B (en) 2010-04-28
WO2008025961A3 (en) 2008-05-02
EP2059611A2 (en) 2009-05-20
JP2010502177A (ja) 2010-01-28

Similar Documents

Publication Publication Date Title
CA2661699A1 (en) Method of diagnosis
Brinch et al. Identification of circulating fetal cell markers by microarray analysis
US20230332233A1 (en) USE OF microRNA (miRNA) MARKER IN PREPARATION OF PRODUCT FOR EVALUATING THERAPEUTIC EFFECT OF OLANZAPINE IN TREATMENT OF SCHIZOPHRENIA (SZ) AND KIT
CN109609653B (zh) 诊断或治疗胶质瘤的分子标记物及其应用
CN108866181B (zh) Mboat1基因在子痫前期中的应用
Shima et al. Alterations in gene expression associated with changes in the state of endothelial differentiation
CN114388066A (zh) 一种房颤心肌纤维化的分析装置、方法
CA2661705A1 (en) Method of diagnosis
CN108796065A (zh) Fam127a在妊娠疾病中的应用
CN108624678A (zh) 一种用于子痫前期诊治的生物标志物
Saber et al. Possible roles for the hominoid-specific DSCR4 gene in human cells
CN105256063A (zh) 肿瘤标志物dmbx1及其应用
US20100184610A1 (en) Method of prognosis
Evans et al. Defining components of early thyroid hormone signalling through temperature-mediated activation of molecular memory in cultured Rana [lithobates] catesbeiana tadpole back skin
Marasca et al. 3D multicolor DNA FISH tool to study nuclear architecture in human primary cells
JP2021093931A (ja) 表皮ターンオーバー遅延の遺伝的素因の判定方法
Varberg et al. Active remodeling of the chromatin landscape directs extravillous trophoblast cell lineage development
Frum et al. Clinical Interventions and Inflammatory Signaling Shape the Transcriptional and Cellular Architecture of the Early Postnatal Lung
CN107190328B (zh) 蜕膜和绒毛配对cDNA芯片
Sivankutty et al. Resolving the molecular niche of pulmonary fibrosis using cryopreserved human precision cut lung slices
CN108728531A (zh) 生物标志物cbx8在子痫前期诊治中的应用
WO2020073935A1 (zh) 一种以皮肤外源性老化靶标筛选活性物的方法及改善皮肤外源性老化的活性物
Brodier et al. A transient decrease in mitochondrial activity is required to establish the ganglion cell fate in retina adapted for high acuity vision
CN108588211A (zh) 一种子痫前期的生物标志物及其应用
CN109182513A (zh) 生物标志物scfd2在阿尔茨海默诊治中的应用

Legal Events

Date Code Title Description
FZDE Discontinued